- Condition: Pelvic Organ Prolapse
Intervention: Procedure: Robotic assisted sacrocolpopexy (RASC)
Sponsors: Cork University Hospital; Lorenzo Dutto
Recruiting - verified May 2012 - Condition: Cardiovascular Disease
Intervention: Dietary Supplement: High/ Low Epicatechin Apples/ Apple Extract/ Granules
Sponsors: Queen's University, Belfast; Queen's University, Belfast
Recruiting - verified April 2012 - Condition: Labouring Parturients Requiring/Requesting Epidural Analgesia as Part of Their Peri-partum Care
Intervention: Device: Epidrum
Sponsors: National Maternity Hospital, Ireland; National Maternity Hospital, Ireland
Recruiting - verified April 2012 - Condition: Bronchiectasis
Intervention:
Sponsors: University of Ulster; University of Ulster; Belfast Health and Social Care Trust; Western Health and Social Care Trust; Queen's University, Belfast; University of Strathclyde
Not yet recruiting - verified March 2012 - Condition: Enteral Feeds
Interventions: Dietary Supplement: Caseinate; Dietary Supplement: Milk Protein Isolate
Sponsors: University College Cork; University College Cork
Completed - verified May 2012 - Condition: Fractured Neck of Femur
Interventions: Drug: Dexamethasone acetate; Drug: Placebo
Sponsors: Cork University Hospital; Cork University Hospital; University of Bristol
Recruiting - verified March 2012 - Condition: High Risk of Medication-related Problems
Intervention: Other: Medicines Management Outpatient service
Sponsors: Queen's University, Belfast; Queen's University, Belfast
Recruiting - verified February 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab; Drug: Paclitaxel; Drug: Lapatinib
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Recruiting - verified February 2012 - Condition: Fractured Neck of Femur
Intervention: Procedure: Femoral nerve block
Sponsors: Cork University Hospital; Cork University Hospital
Completed - verified February 2012 - Condition: Dietary Modification
Interventions: Behavioral: Level 1 Dietary Intake; Behavioral: Level 2: Dietary Intake + Phenotype; Behavioral: Level 3 Dietary + Phenotype + Genotype; Behavioral: Level 0 Control Group
Sponsors: Newcastle University; Newcastle University; University College Dublin; Maastricht University; University of Oslo; University of Navarra; Harokopio University; University of Reading; National Food and Nutrition InstitutE; Technische Universität München; University of Newcastle Upon-Tyne
Not yet recruiting - verified February 2012 - Conditions: Obesity; Diabetes; Cardiovascular Diseases
Interventions: Dietary Supplement: Olive oil; Dietary Supplement: Olive oil and fish powder; Dietary Supplement: Olive oil and macadamia oil; Dietary Supplement: Deadaptation
Sponsors: University of Limerick; University of Limerick
Completed - verified January 2012 - Condition: Urinary Retention
Intervention: Other: Removal of urethral catheter
Sponsors: University College Hospital Galway; University College Hospital Galway
Recruiting - verified January 2012 - Condition: Her2 Positive Metastatic Breast Cancer
Interventions: Drug: Myocet; Drug: Lapatinib
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Recruiting - verified December 2011 - Conditions: Food Allergy; Eczema; Obesity
Intervention:
Sponsors: National Children's Research Centre, Ireland; National Children's Research Centre, Ireland; Food Standards Agency, United Kingdom
Active, not recruiting - verified December 2011 - Condition: Performance and Safety of a New Supraglottic Airway Device
Intervention: Device: Placement and use of Baska mask
Sponsors: University College Hospital Galway; University College Hospital Galway
Completed - verified March 2012 - Condition: Breast Cancer
Interventions: Drug: Docetaxel, Carboplatin and Trastuzumab; Drug: Docetaxel, Carboplatin and Lapatinib; Drug: Docetaxel, Carboplatin, Trastuzumab and Lapatinib
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Recruiting - verified December 2011 - Conditions: Hypotension; Low Blood Pressure; Prematurity of Fetus
Interventions: Drug: Dopamine hydrochloride; Drug: Dextrose 5%
Sponsors: University College Cork; University College Cork; BrePco Biopharma Limited; Cork University Hospital; Katholieke Universiteit Leuven; Univerzita Karlova v Praze; Centre hospitalier universitaire Sainte-Justine; University College Dublin; Coombe Women and Infants University Hospital; University of Alberta; Royal College of Surgeons, Ireland; GABO:milliarium mbH & Co. KG; National de la Santé et de la Recherche Medicale; University College, London; Clininfo S.A.
Not yet recruiting - verified November 2011 - Condition: Performance and Safety of an Airway Management Device
Intervention: Device: supraglottic airway placement and use
Sponsors: University College Hospital Galway; University College Hospital Galway
Recruiting - verified December 2011 - Condition: Glioblastoma Multiforme
Interventions: Radiation: Radiotherapy; Radiation: Radiotherapy
Sponsors: International Atomic Energy Agency; International Atomic Energy Agency; Fundación Escuela de Medicina Nuclear; N.N. Alexandrov National Cancer Centre of Belarus; Hospital A.C. Camargo; Irmandade Santa Casa de Misericórdia de Porto Alegre; Instituto de Radiomedicina (IRAM); Postgraduate Institute of Medical Education and Research; Cipto Mangunkusumo General Hospital; Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology; Chiang Mai University; Institut National de Cancer Salah Azaiz; Wilson Roa Professional Corporation; All Ireland Cooperative Oncology Research Group; Ege University; High Technology Medical Center
Recruiting - verified December 2011 - Condition: Malaria
Interventions: Biological: ChAd63 CS; Biological: ChAd63 CS, MVA CS; Biological: ChAd63 CS; Biological: ChAd63, MVA CS
Sponsors: University of Oxford; University of Oxford
Recruiting - verified December 2011 - Condition: Peripheral Vestibular Disease
Intervention: Other: Vestibular Rehabilitation
Sponsors: Royal College of Surgeons, Ireland; Royal College of Surgeons, Ireland; Beaumont Hospital; Emory University; Royal Victoria Eye and Ear Hospital
Recruiting - verified September 2011 - Conditions: Heart Failure; Myocardial Infarction
Interventions: Drug: mecasermin; Drug: mecasermin; Drug: 0.9% sodium chloride injection
Sponsors: University College Cork; University College Cork
Recruiting - verified October 2011 - Condition: Adverse Drug Reactions
Interventions: Other: Structured expert pharmacist review; Other: No Intervention
Sponsors: University College Cork; University College Cork
Enrolling by invitation - verified November 2011 - Condition: Adverse Drug Reaction
Interventions: Other: Application of STOPP/START criteria; Other: Normal pharmaceutical care
Sponsors: University College Cork; University College Cork
Enrolling by invitation - verified November 2011 - Condition: Epilepsy
Intervention:
Sponsors: Royal College of Surgeons, Ireland; Royal College of Surgeons, Ireland; St. James's Hospital; University College, London; Erasme University Hospital; Duke University
Not yet recruiting - verified July 2011 - Condition: Vitamin D Status as Reflected by Serum 25-hydroxyvitamin D
Interventions: Dietary Supplement: vitamin D3; Dietary Supplement: 25-hydroxyvitamin D3; Dietary Supplement: 25-hydroxyvitamin D (20 microgram/day); Dietary Supplement: Placebo
Sponsors: University College Cork; University College Cork
Active, not recruiting - verified June 2011 - Conditions: Yaws; Treponema Infection; Neglected Tropical Disease
Interventions: Drug: Penicillin-G-benzathine; Drug: Azithromycin
Sponsors: Lihir Medical Centre; Lihir Medical Centre; Centre For International Health
Completed - verified April 2012 - Condition: Crohn's Disease
Interventions: Dietary Supplement: Vitamin D3; Other: Placebo
Sponsors: University of Dublin, Trinity College; University of Dublin, Trinity College; Irish Research Council for Science, Engineering and Technology
Not yet recruiting - verified June 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: filgrastim; Drug: carboplatin; Drug: paclitaxel; Other: pharmacological study; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group
Recruiting - verified May 2012 - Conditions: Pulmonary Arterial Hypertension (PAH); Pulmonary Hypertension (PH)
Intervention:
Sponsors: Dresden University of Technology; Dresden University of Technology
Recruiting - verified February 2012 - Condition: Osteoarthritis
Interventions: Dietary Supplement: AquaCal; Dietary Supplement: AquaPT
Sponsors: University College Cork; Andrea Doolan
Completed - verified May 2012 - Condition: Right Colon Tumors
Intervention: Procedure: Patients will be divided in two groups- those having right colectomy by standard laparoscopy and those having Single Incision Laparoscopic Surgery (SILS)
Sponsors: Irish Clinical Outcomes in Research and Education; Irish Clinical Outcomes in Research and Education; The Cleveland Clinic
Recruiting - verified March 2012 - Conditions: Acupuncture; Morphine Induced Pruritis
Interventions: Device: ACUPUNCTURE AT LI11; Device: SHAM ACUPUNCTURE
Sponsors: Letterkenny General Hospital; Letterkenny General Hospital
Completed - verified January 2011 - Condition: Postpoliomyelitis Syndrome
Intervention: Other: Upper Limb Ergometry
Sponsors: Royal College of Surgeons, Ireland; Royal College of Surgeons, Ireland; Post Polio Support Group Ireland; Beaumont Hospital
Recruiting - verified October 2011 - Condition: Non-cardiac Surgery
Intervention:
Sponsors: Queen Mary University of London; Queen Mary University of London; European Society of Anaesthesiology; European Society of Intensive Care Medicine
Completed - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Pulmonary Rehabilitation
Sponsors: Beaumont Hospital; Beaumont Hospital
Completed - verified February 2012 - Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily; Drug: kaletra dosed twice daily
Sponsors: PENTA Foundation; PENTA Foundation; Medical Research Council; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - verified February 2012 - Condition: Lung Cancer
Interventions: Other: questionnaire administration; Procedure: quality-of-life assessment; Radiation: 3-dimensional conformal radiation therapy; Radiation: palliative radiation therapy; Radiation: whole-brain radiation therapy
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified August 2010 - Condition: Colorectal Cancer
Intervention: Device: EndoVe endoscopic electroporation
Sponsors: Mercy University Hospital, Cork, Ireland; Mercy University Hospital, Cork, Ireland
Recruiting - verified September 2011 - Conditions: Metastatic Cancer; Prostate Cancer
Interventions: Drug: docetaxel; Genetic: RNA analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: circulating tumor cell analysis; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified January 2011 - Conditions: Endometrial Cancer; Gastrointestinal Complications; Radiation Toxicity; Urinary Complications
Interventions: Other: questionnaire administration; Procedure: adjuvant therapy; Procedure: assessment of therapy complications; Procedure: quality-of-life assessment; Radiation: brachytherapy; Radiation: external beam radiation therapy; Radiation: intensity-modulated radiation therapy; Radiation: radiation therapy treatment planning/simulation
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified July 2010 - Condition: Postoperative Nausea and Vomiting
Intervention: Other: fluid administration
Sponsors: The Rotunda Hospital; The Rotunda Hospital
Completed - verified May 2010 - Conditions: HIV Infections; Hepatitis C
Interventions: Drug: Raltegravir; Drug: Atazanavir/Ritonavir
Sponsors: St. James's Hospital; St. James's Hospital
Recruiting - verified March 2010 - Condition: Coronary Artery Disease
Intervention: Device: Radi pressure wire (pressure wire assessment)
Sponsors: Southampton University Hospitals NHS Trust; Southampton University Hospitals NHS Trust
Recruiting - verified July 2011 - Conditions: Depression; Alcohol Use Disorder
Intervention: Other: Supportive SMS text messages
Sponsors: University of Dublin, Trinity College; University of Dublin, Trinity College; St Patrick's Hospital, Ireland
Completed - verified January 2012 - Conditions: Airway; Difficult Intubation; Airway Device
Interventions: Device: macintosh laryngoscope; Device: C-MAC laryngoscope; Device: Airtraq device
Sponsors: University College Hospital Galway; University College Hospital Galway
Recruiting - verified July 2010 - Condition: Cancer
Intervention: Behavioral: Exercise programme
Sponsors: University of Dublin, Trinity College; University of Dublin, Trinity College; Health Research Board, Ireland
Completed - verified November 2009 - Conditions: Bacterial Translocation; Surgical Site Infection; Abdominal Surgery; Wound Infection
Intervention:
Sponsors: St Vincent's University Hospital, Ireland; St Vincent's University Hospital, Ireland
Completed - verified November 2009 - Conditions: Pain; Radiation Toxicity; Spinal Cord Compression; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Radiation: Cumulative BED ≤ 100; Radiation: Cumulative BED ≤ 130 Gy2
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Recruiting - verified March 2012 - Condition: Giant Cell Arteritis
Interventions: Procedure: Ultrasound of temporal and axillary arteries; Procedure: Temporal artery biopsy
Sponsors: University of Oxford; University of Oxford; University of Sheffield; Southend University Hospital; Nuffield Orthopaedic Centre NHS Trust; John Radcliffe Hospital; The Leeds Teaching Hospitals NHS Trust; University of Bristol; London School of Hygiene and Tropical Medicine; Medical Center for Rheumatology Berlin-Buch
Recruiting - verified January 2012 - Conditions: Breast Cancer; Cardiac Toxicity
Interventions: Biological: trastuzumab; Other: laboratory biomarker analysis; Procedure: assessment of therapy complications
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified August 2009 - Conditions: Spinal Cord Compression; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Radiation: radiation therapy
Sponsors: All Ireland Cooperative Oncology Research Group; All Ireland Cooperative Oncology Research Group
Recruiting - verified March 2012 - Conditions: Self Concept; Body Fat Composition; Depression; Perceived Social Support
Interventions: Other: Exercise; Behavioral: Online Cognitive Behavioural Therapy
Sponsors: Dublin City University; Dublin City University
Completed - verified July 2011 - Condition: Prostate Cancer
Interventions: Other: laboratory biomarker analysis; Other: medical chart review; Other: questionnaire administration
Sponsors: National Cancer Institute (NCI); Institute of Cancer Research, United Kingdom
Recruiting - verified August 2009 - Conditions: Lung Cancer; Metastatic Cancer
Interventions: Procedure: computed tomography; Radiation: 3-dimensional conformal radiation therapy; Radiation: fludeoxyglucose F 18; Radiation: radiation therapy treatment planning/simulation
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified August 2010 - Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: releasing hormone agonist therapy; Genetic: protein expression analysis; Genetic: proteomic profiling; Other: laboratory biomarker analysis; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified August 2009 - Condition: Prostate Cancer
Interventions: Other: questionnaire administration; Procedure: quality-of-life assessment; Radiation: image-guided radiation therapy; Radiation: intensity-modulated radiation therapy; Radiation: radiation therapy treatment planning/simulation
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified July 2009 - Condition: Breast Cancer
Interventions: Biological: bevacizumab; Drug: cyclophosphamide; Drug: docetaxel; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified May 2009 - Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide phosphate; Genetic: gene expression analysis; Genetic: polymorphism analysis; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); Children's Cancer and Leukaemia Group
Recruiting - verified June 2009 - Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Genetic: molecular genetic technique; Other: mass spectrometry; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); Children's Cancer and Leukaemia Group
Recruiting - verified June 2009 - Condition: Cardiovascular Disease
Intervention: Other: Fruit and vegetable intervention
Sponsors: Queen's University, Belfast; Queen's University, Belfast
Completed - verified August 2011 - Conditions: Polycythemia Vera; Essential Thrombocythemia
Intervention: Drug: HDAC inhibitor (MK-0683)
Sponsors: Copenhagen University Hospital at Herlev; Copenhagen University Hospital at Herlev
Active, not recruiting - verified December 2011 - Condition: Leukemia
Interventions: Biological: pegfilgrastim; Biological: rituximab; Drug: cyclophosphamide; Drug: fludarabine phosphate; Genetic: cytogenetic analysis; Genetic: fluorescence in situ hybridization; Genetic: gene expression analysis; Genetic: mutation analysis; Genetic: protein expression analysis; Other: flow cytometry; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified January 2009 - Condition: Leukemia
Interventions: Drug: nilotinib; Genetic: cytogenetic analysis; Genetic: mutation analysis; Genetic: polymerase chain reaction; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified January 2009 - Condition: Breast Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy; Radiation: brachytherapy
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified January 2009 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: cyclophosphamide; Drug: melphalan; Procedure: autologous hematopoietic stem cell transplantation
Sponsors: National Cancer Institute (NCI); Leeds Cancer Centre at St. James's University Hospital
Recruiting - verified June 2009 - Conditions: Deep Vein Thrombosis; Pulmonary Embolism
Interventions: Other: Discontinue anticoagulant therapy (Negative d-dimer); Other: Continue on anticoagulant therapy (positive d-dimer)
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified April 2012 - Conditions: Cardiac Surgery; Cardiopulmonary Bypass
Interventions: Drug: Sodium Bicarbonate; Drug: Sodium Chloride
Sponsors: Austin Health; Austin Health
Recruiting - verified November 2009 - Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel; Drug: Placebo
Sponsors: Deutsches Herzzentrum Muenchen; Deutsches Herzzentrum Muenchen
Recruiting - verified April 2012 - Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the TesticleCondition: Testicular Germ Cell Tumor
Interventions: Other: questionnaire administration; Procedure: computed tomography; Procedure: magnetic resonance imaging; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified July 2009 - Condition: Cellulitis/Erysipelas of the Leg
Interventions: Drug: Penicillin VK; Other: placebo
Sponsors: University of Nottingham; University of Nottingham; Action Medical Research; UK Dermatology Clinical Trials Network
Active, not recruiting - verified January 2012 - Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); All Ireland Cooperative Oncology Research Group
Recruiting - verified August 2007 - CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With IfosfamideConditions: Chemotherapeutic Agent Toxicity; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Genetic: gene expression analysis; Genetic: polymorphism analysis; Procedure: management of therapy complications
Sponsors: National Cancer Institute (NCI); Children's Cancer and Leukaemia Group
Recruiting - verified June 2009 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: motexafin gadolinium; Drug: temozolomide; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Cancer and Leukaemia Group
Recruiting - verified June 2009 - Conditions: Lung Cancer; Precancerous Condition
Interventions: Other: cytology and cytometry specimen collection procedure; Other: Chest x ray; Procedure: Autofluorescence bronchoscopy; Procedure: CT scan
Sponsors: University College, London; University College, London
Completed - verified December 2011 - Conditions: Ulcerative Colitis; Crohn's Disease
Interventions: Biological: Bifidobacterium infantis 35624; Biological: Lactobacillus salivarius UCC118; Biological: Placebo
Sponsors: University College Cork; University College Cork; European Commission
Active, not recruiting - verified August 2007 - Conditions: Dyskeratosis Congenita; Fanconi Anemia; Myelodysplastic Syndromes; Nonmalignant Neoplasm; Pearson Marrow-pancreas Syndrome; Shwachman-diamond Syndrome
Interventions: Genetic: polymerase chain reaction; Other: flow cytometry; Other: immunologic technique; Procedure: biopsy
Sponsors: University Hospital Freiburg; University Hospital Freiburg
Recruiting - verified December 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified April 2012 - Condition: Respiratory Insufficiency of Prematurity
Interventions: Device: nCPAP; Device: NIPPV
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Completed - verified March 2012 - Condition: Breast Neoplasms
Interventions: Drug: Sevoflurane; Drug: Sevoflurane
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified May 2012 - Conditions: Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
Interventions: Drug: chemotherapy; Drug: dexamethasone; Procedure: plasmapheresis
Sponsors: National Cancer Institute (NCI); University of Glasgow
Recruiting - verified June 2007 - Conditions: Lung Cancer; Metastatic Cancer
Interventions: Drug: dexamethasone; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified January 2007 - Condition: Childhood Langerhans Cell Histiocytosis
Interventions: Drug: leucovorin calcium; Drug: methotrexate; Drug: prednisolone; Drug: vinblastine sulfate
Sponsors: National Cancer Institute (NCI); Histiocyte Society
Recruiting - verified May 2007 - Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer
Interventions: Biological: bleomycin sulfate; Drug: carboplatin; Drug: etoposide; Procedure: conventional surgery
Sponsors: National Cancer Institute (NCI); Children's Cancer and Leukaemia Group
Active, not recruiting - verified February 2006 - Condition: Prostate Cancer
Interventions: Drug: celecoxib; Drug: docetaxel; Drug: prednisolone; Drug: releasing hormone agonist therapy; Drug: zoledronic acid; Drug: abiraterone; Procedure: orchiectomy
Sponsors: Medical Research Council; Medical Research Council
Recruiting - verified March 2012 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Condition: Breast Cancer
Intervention: Drug: anastrozole
Sponsors: Queen Mary University of London; Jill Knox
Active, not recruiting - verified April 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: paclitaxel; Procedure: adjuvant therapy; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: National Cancer Institute (NCI); Royal College of Obstetricians and Gynecologists
Recruiting - verified May 2007 - Condition: Breast Cancer
Interventions: Drug: tamoxifen citrate; Drug: Anastrozole
Sponsors: Queen Mary University of London; Jill Knox; Cancer Research UK
Active, not recruiting - verified May 2012 - Condition: Neuroblastoma
Interventions: Biological: filgrastim; Biological: monoclonal antibody Ch14.18; Drug: busulfan; Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: isotretinoin; Drug: melphalan; Drug: vincristine sulfate; Procedure: bone marrow ablation with stem cell support; Procedure: conventional surgery; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); University Hospitals, Leicester
Recruiting - verified August 2010 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Lymphoma
Interventions: Drug: chlorambucil; Drug: dexamethasone; Drug: fludarabine phosphate; Drug: mitoxantrone hydrochloride
Sponsors: National Cancer Institute (NCI); Lymphoma Trials Office
Active, not recruiting - verified March 2007 - Condition: Melanoma (Skin)
Interventions: Biological: pegylated interferon alfa; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified October 2000 - Condition: Leukemia
Interventions: Drug: chlorambucil; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: fludarabine phosphate; Drug: prednisolone; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Leukemia Research Fund; Medical Research Council
Active, not recruiting - verified January 2006 - Condition: Prostate Cancer
Interventions: Drug: flutamide; Drug: triptorelin; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Saint Luke's Hospital
Active, not recruiting - verified December 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified March 2012 - Condition: Neuroblastoma
Intervention: Procedure: surgical procedure
Sponsors: National Cancer Institute (NCI); Societe Internationale d'Oncologie Pediatrique
Recruiting - verified July 2007
 |
Join Clinical Trials by University in Northern Ireland, United Kingdom |
